WebApr 13, 2024 · CytomX Therapeutics (NASDAQ:CTMX – Get Rating) and Stoke Therapeutics (NASDAQ:STOK – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, profitability, valuation and … WebApr 14, 2024 · Cambridge Investment Research Advisors Inc. now owns 14,928 shares of the company’s stock worth $618,000 after purchasing an additional 593 shares during the last quarter. VitalStone Financial...
NexGen Energy (TSE:NXE) Shares Up 3.1% - ETF Daily News
WebCytomX Therapeutics Inc (CTMX) Stock Price Today, News, Quotes, FAQs and Fundamentals 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here. CTMX CytomX Therapeutics Inc 2,597 $1.54 $0.03 (1.99%) Today Market Cap $100M Volume (M) 506,367.00 52-Wk High $3.02 52-Wk Low $1.17 About Feed Sentiment … Web2 days ago · CytomX Therapeutics - CTMX - Stock Price Today - Zacks CytomX Therapeutics (CTMX) (Delayed Data from NSDQ) $1.86 USD -0.10 (-5.10%) Updated … gps wilhelmshaven personalabteilung
CTMX CytomX Therapeutics Inc. Stock Price & News - WSJ
WebMar 30, 2024 · CTMX stock opened at $1.54 on Thursday. The company has a market capitalization of $101.43 million, a PE ratio of -1.03 and a beta of 0.69. CytomX Therapeutics, Inc. has a 12 month low of $1.17... WebMar 28, 2024 · The company’s shares closed last Monday at $1.79. According to TipRanks.com, Darout is a 4-star analyst with an average return of 7.4% and a 36.5% success rate. Darout covers the Healthcare... WebShares Sold Short 1.27 M Change from Last -7.69% Percent of Float 1.97% Stock Money Flow N/A PROFILE ( CTMX) CytomX Therapeutics, Inc. engages in the development of … gps wilhelmshaven